Reasons Some Enrollees May Face Higher Premiums
TL/DR –
Medicare open enrollment is currently underway, and changes in 2023 could result in raised premiums, increased out-of-pocket caps, and fewer drug coverage options for enrollees. For example, the out-of-pocket expense cap for Medicare Part D drugs will rise from $2,100 to $2,400, and the standard deductible will increase from $615 to $700. Furthermore, monthly premiums could increase by $50 for 2 million enrollees in certain plans if they do not change their plan before December 7, 2023.
“`html
Medicare Open Enrollment: Changes and Implications
During the current open enrollment for Medicare, specialists are advising enrollees to explore different plans. According to predictions, if enrollees do not amend their plans before December 7, monthly Medicare Part D premiums could rise by $50 or more for 2 million enrollees. Additionally, several other modifications in Medicare are anticipated for the next year.
Key Upcoming Changes in Medicare
Several alterations in Medicare are set to take place which might lead to an increase in premiums, a surge in out-of-pocket caps, and fewer options for drug coverage. Open enrollment for Medicare started on Thursday, October 15, and will continue until December 7. Enrollees have the choice between traditional Medicare and privately run Medicare Advantage plans in their location, in addition to prescription drug plans. These changes come into effect on January 1.
Medicare Part D: What to Expect
The cap on yearly out-of-pocket expenses for Medicare Part D drugs will rise to $2,400 from $2,100 in 2026. The standard deductible will also rise from $615 to $700. The Trump administration plans on discontinuing a temporary Part D premium subsidy that was originally implemented by former President Joe Biden’s administration in 2024. This subsidy helped offset premiums and was intended to reduce patients’ Medicare Part D prescription drug costs in response to the effects of the 2022 Inflation Reduction Act.
Rising Premiums and their Impact
Based on findings by KFF, a health policy research organization, enrollees in United AARP-branded Part D plans who do not change their plans will experience a monthly premium increase by $50 or more across all 50 states. In 37 states, the premiums will increase by over $75 a month, while in four states, the increase will exceed $100. For the AARP Medicare Rx Saver plan, monthly premiums will escalate by $50 or more for enrollees in 33 states. However, KFF suggests that “a majority of Part D enrollees will not be affected by premium changes and may not face premium increases of any magnitude.”
The Importance of Exploring Options in Medicare Plans
The KFF points out that cheaper plans exist, but many enrollees do not compare plans or switch during open enrollment. Nancy LeaMond, AARP’s Executive Vice President and Chief Advocacy Officer, stated, “Higher health care costs are making it harder for older Americans to afford the care they need. With costs and coverage changing every year, it’s more important than ever to shop around, compare your options, and choose the coverage that’s best for you.”
Medicare Coverage for More Drugs
From January 1, Medicare coverage will be extended to include new Medicare-negotiated prices for 15 drugs, including weight-loss and diabetes medications Ozempic, Rybelsus, and Wegovy. Other drugs such as Trelegy Ellipta, Xtandi, Pomalyst, Ibrance, Ofev, Linzess, Calquence, Austedo/Austedo XR, Breo Ellipta, Tradjenta, Xifaxan, Vraylar, Janumet/Janumet XR, and Otezla will also be covered. The Centers for Medicare and Medicaid anticipate these changes will reduce prescription drug coverage for people enrolled in Medicare by $685 million in 2027.
This article includes information from The Associated Press, KFF and previous FOX Local reporting.
“`
—
Read More US Economic News